The antitumor activity of miR-146a is characterized by suppressing proliferation and promoting apoptosis of NSCLC cells by inhibiting EGFR and the downstream pathways (ERK-1/-2, AKT, and STAT). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.